Trials / Completed
CompletedNCT00858650
Registry of Hypogonadism in Men
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 999 (actual)
- Sponsor
- Carelon Research · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of the Registry of HYpogonadism in MEn (RHYME) is to establish and maintain a large, multi-national prospective registry of male patients who have been diagnosed with male hypogonadism (HG), also known as androgen deficiency or testosterone deficiency.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Standard of Care | Standard of care may or may not include use of testosterone replacement therapy |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2009-03-10
- Last updated
- 2016-08-24
Locations
25 sites across 6 countries: Germany, Italy, Netherlands, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT00858650. Inclusion in this directory is not an endorsement.